Trials / Completed
CompletedNCT00997074
Efficacy Study of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion
The Effect of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion: A Double-blind Randomized Placebo Controlled Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
In the current study, we want to evaluate the prophylactic use of ibuprofen versus a placebo for medical abortion by mifepristone and misoprostol, at a gestational age of up to 7 weeks, in regard to the effect on pain relief and the overall procedure success. expected results: The prophylactic use of NSAIDs could offer significant pain relief and thereby a reduction in the need for additional pain relievers compared to the placebo, without interfering with the outcome of medical abortion
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ibuprofen | The most common side effect observed during medical abortion using mifepristone together with misoprostol is abdominal pain. The use of ibuprofen was not shown to interfere with the action of misoprostol to induce uterine contractions and pregnancy expulsion. |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2009-10-16
- Last updated
- 2012-02-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00997074. Inclusion in this directory is not an endorsement.